位置:首页 > 蛋白库 > NAV3_HUMAN
NAV3_HUMAN
ID   NAV3_HUMAN              Reviewed;        2385 AA.
AC   Q8IVL0; Q8NFW7; Q9Y2E7;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   03-AUG-2022, entry version 147.
DE   RecName: Full=Neuron navigator 3;
DE   AltName: Full=Pore membrane and/or filament-interacting-like protein 1;
DE   AltName: Full=Steerin-3;
DE   AltName: Full=Unc-53 homolog 3;
DE            Short=unc53H3;
GN   Name=NAV3; Synonyms=KIAA0938, POMFIL1, STEERIN3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND VARIANT
RP   ALA-45.
RX   PubMed=15158073; DOI=10.1016/j.devbrainres.2004.03.004;
RA   Peeters P.J., Baker A., Goris I., Daneels G., Verhasselt P.,
RA   Luyten W.H.M.L., Geysen J.J.G.H., Kass S.U., Moechars D.W.E.;
RT   "Sensory deficits in mice hypomorphic for a mammalian homologue of unc-
RT   53.";
RL   Brain Res. Dev. Brain Res. 150:89-101(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 82-2385 (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=12079279; DOI=10.1006/geno.2002.6799;
RA   Maes T., Barcelo A., Buesa C.;
RT   "Neuron navigator: a human gene family with homology to unc-53, a cell
RT   guidance gene from Caenorhabditis elegans.";
RL   Genomics 80:21-30(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 930-2385 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10231032; DOI=10.1093/dnares/6.1.63;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:63-70(1999).
RN   [5]
RP   IDENTIFICATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=12062803; DOI=10.1016/s0378-1119(02)00567-x;
RA   Coy J.F., Wiemann S., Bechmann I., Baechner D., Nitsch R., Kretz O.,
RA   Christiansen H., Poustka A.;
RT   "Pore membrane and/or filament interacting like protein 1 (POMFIL1) is
RT   predominantly expressed in the nervous system and encodes different protein
RT   isoforms.";
RL   Gene 290:73-94(2002).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION, VARIANT LYS-2200, TISSUE SPECIFICITY, AND
RP   FUNCTION.
RX   PubMed=16166283; DOI=10.1158/0008-5472.can-04-0366;
RA   Karenko L., Hahtola S., Paeivinen S., Karhu R., Syrjae S., Kaehkoenen M.,
RA   Nedoszytko B., Kytoelae S., Zhou Y., Blazevic V., Pesonen M., Nevala H.,
RA   Nupponen N., Sihto H., Krebs I., Poustka A., Roszkiewicz J., Saksela K.,
RA   Peterson P., Visakorpi T., Ranki A.;
RT   "Primary cutaneous T-cell lymphomas show a deletion or translocation
RT   affecting NAV3, the human UNC-53 homologue.";
RL   Cancer Res. 65:8101-8110(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1459 AND SER-1463, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
CC   -!- FUNCTION: May regulate IL2 production by T-cells. May be involved in
CC       neuron regeneration. {ECO:0000269|PubMed:16166283}.
CC   -!- SUBCELLULAR LOCATION: Nucleus outer membrane {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IVL0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IVL0-2; Sequence=VSP_025269;
CC       Name=3;
CC         IsoId=Q8IVL0-3; Sequence=VSP_025268, VSP_025269;
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain. Expressed at low levels
CC       in heart and placenta. Present in activated T-cells but not in resting
CC       T-cells (at protein level). Down-regulated in primary neuroblastoma.
CC       {ECO:0000269|PubMed:12062803, ECO:0000269|PubMed:12079279,
CC       ECO:0000269|PubMed:15158073, ECO:0000269|PubMed:16166283}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal brain.
CC       {ECO:0000269|PubMed:12062803}.
CC   -!- DISEASE: Note=A chromosomal aberration disrupting NAV3 has been found
CC       in patients with Sezary syndrome (PubMed:16166283). Translocation
CC       t(12;18)(q21;q21.2) (PubMed:16166283). {ECO:0000269|PubMed:16166283}.
CC   -!- SIMILARITY: Belongs to the Nav/unc-53 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ488201; CAD32554.1; -; mRNA.
DR   EMBL; AC073571; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073608; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090020; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138331; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF397731; AAM73757.1; -; mRNA.
DR   EMBL; AB023155; BAA76782.2; -; mRNA.
DR   CCDS; CCDS41815.1; -. [Q8IVL0-2]
DR   CCDS; CCDS66432.1; -. [Q8IVL0-1]
DR   RefSeq; NP_001019554.1; NM_001024383.1. [Q8IVL0-1]
DR   RefSeq; NP_055718.4; NM_014903.5. [Q8IVL0-2]
DR   RefSeq; XP_011537246.1; XM_011538944.2. [Q8IVL0-3]
DR   AlphaFoldDB; Q8IVL0; -.
DR   SMR; Q8IVL0; -.
DR   BioGRID; 124604; 20.
DR   IntAct; Q8IVL0; 4.
DR   MINT; Q8IVL0; -.
DR   STRING; 9606.ENSP00000381007; -.
DR   GlyConnect; 2059; 1 N-Linked glycan (1 site).
DR   GlyGen; Q8IVL0; 3 sites, 2 N-linked glycans (1 site), 1 O-linked glycan (2 sites).
DR   iPTMnet; Q8IVL0; -.
DR   PhosphoSitePlus; Q8IVL0; -.
DR   SwissPalm; Q8IVL0; -.
DR   BioMuta; NAV3; -.
DR   DMDM; 313104213; -.
DR   EPD; Q8IVL0; -.
DR   jPOST; Q8IVL0; -.
DR   MassIVE; Q8IVL0; -.
DR   MaxQB; Q8IVL0; -.
DR   PaxDb; Q8IVL0; -.
DR   PeptideAtlas; Q8IVL0; -.
DR   PRIDE; Q8IVL0; -.
DR   ProteomicsDB; 70721; -. [Q8IVL0-1]
DR   ProteomicsDB; 70722; -. [Q8IVL0-2]
DR   ProteomicsDB; 70723; -. [Q8IVL0-3]
DR   Antibodypedia; 29726; 77 antibodies from 19 providers.
DR   DNASU; 89795; -.
DR   Ensembl; ENST00000397909.7; ENSP00000381007.2; ENSG00000067798.16. [Q8IVL0-1]
DR   Ensembl; ENST00000536525.6; ENSP00000446132.2; ENSG00000067798.16. [Q8IVL0-2]
DR   GeneID; 89795; -.
DR   KEGG; hsa:89795; -.
DR   MANE-Select; ENST00000397909.7; ENSP00000381007.2; NM_001024383.2; NP_001019554.1.
DR   UCSC; uc001syo.5; human. [Q8IVL0-1]
DR   CTD; 89795; -.
DR   DisGeNET; 89795; -.
DR   GeneCards; NAV3; -.
DR   HGNC; HGNC:15998; NAV3.
DR   HPA; ENSG00000067798; Tissue enhanced (brain, ovary).
DR   MIM; 611629; gene.
DR   neXtProt; NX_Q8IVL0; -.
DR   OpenTargets; ENSG00000067798; -.
DR   PharmGKB; PA31453; -.
DR   VEuPathDB; HostDB:ENSG00000067798; -.
DR   eggNOG; ENOG502QPT3; Eukaryota.
DR   GeneTree; ENSGT00940000158014; -.
DR   HOGENOM; CLU_001002_1_0_1; -.
DR   InParanoid; Q8IVL0; -.
DR   OMA; SSLYSTX; -.
DR   OrthoDB; 21830at2759; -.
DR   PhylomeDB; Q8IVL0; -.
DR   TreeFam; TF329881; -.
DR   PathwayCommons; Q8IVL0; -.
DR   SignaLink; Q8IVL0; -.
DR   BioGRID-ORCS; 89795; 4 hits in 1069 CRISPR screens.
DR   ChiTaRS; NAV3; human.
DR   GenomeRNAi; 89795; -.
DR   Pharos; Q8IVL0; Tbio.
DR   PRO; PR:Q8IVL0; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q8IVL0; protein.
DR   Bgee; ENSG00000067798; Expressed in middle temporal gyrus and 164 other tissues.
DR   ExpressionAtlas; Q8IVL0; baseline and differential.
DR   Genevisible; Q8IVL0; HS.
DR   GO; GO:0005640; C:nuclear outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; IMP:UniProtKB.
DR   GO; GO:0007026; P:negative regulation of microtubule depolymerization; IMP:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0022008; P:neurogenesis; IEA:InterPro.
DR   GO; GO:0031116; P:positive regulation of microtubule polymerization; IMP:UniProtKB.
DR   CDD; cd00014; CH; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR003959; ATPase_AAA_core.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR039041; Nav/unc-53.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR12784; PTHR12784; 1.
DR   Pfam; PF00004; AAA; 1.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00382; AAA; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   PROSITE; PS50021; CH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil; Membrane;
KW   Nucleus; Phosphoprotein; Reference proteome.
FT   CHAIN           1..2385
FT                   /note="Neuron navigator 3"
FT                   /id="PRO_0000286976"
FT   DOMAIN          77..184
FT                   /note="Calponin-homology (CH)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REGION          17..38
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          203..625
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          877..1312
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1351..1370
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1410..1468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1650..1778
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1850..1881
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2360..2385
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          679..707
FT                   /evidence="ECO:0000255"
FT   COILED          1562..1653
FT                   /evidence="ECO:0000255"
FT   COILED          1794..1861
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        203..247
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        257..365
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        424..443
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        461..495
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        516..550
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        557..573
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        591..625
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        879..922
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        923..957
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        978..992
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1056..1094
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1110..1194
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1208..1231
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1264..1312
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1448..1468
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1669..1688
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1705..1723
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1860..1881
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1459
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         1463
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   VAR_SEQ         1250..1426
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10231032"
FT                   /id="VSP_025268"
FT   VAR_SEQ         1767..1788
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10231032,
FT                   ECO:0000303|PubMed:12079279"
FT                   /id="VSP_025269"
FT   VARIANT         45
FT                   /note="T -> A (in dbSNP:rs10735309)"
FT                   /evidence="ECO:0000269|PubMed:15158073"
FT                   /id="VAR_032249"
FT   VARIANT         210
FT                   /note="S -> W (in dbSNP:rs34195711)"
FT                   /id="VAR_032250"
FT   VARIANT         2200
FT                   /note="E -> K (in a patient with Sezary syndrome)"
FT                   /evidence="ECO:0000269|PubMed:16166283"
FT                   /id="VAR_032251"
FT   CONFLICT        677
FT                   /note="D -> G (in Ref. 1; CAD32554)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        924
FT                   /note="L -> V (in Ref. 3; AAM73757)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2385 AA;  255648 MW;  23706AF34D2018FA CRC64;
     MPVLGVASKL RQPAVGSKPV HTALPIPNLG TTGSQHCSSR PLELTETESS MLSCQLALKS
     TCEFGEKKPL QGKAKEKEDS KIYTDWANHY LAKSGHKRLI KDLQQDIADG VLLAEIIQII
     ANEKVEDING CPRSQSQMIE NVDVCLSFLA ARGVNVQGLS AEEIRNGNLK AILGLFFSLS
     RYKQQQHHQQ QYYQSLVELQ QRVTHASPPS EASQAKTQQD MQSSLAARYA TQSNHSGIAT
     SQKKPTRLPG PSRVPAAGSS SKVQGASNLN RRSQSFNSID KNKPPNYANG NEKDSSKGPQ
     SSSGVNGNVQ PPSTAGQPPA SAIPSPSASK PWRSKSMNVK HSATSTMLTV KQSSTATSPT
     PSSDRLKPPV SEGVKTAPSG QKSMLEKFKL VNARTALRPP QPPSSGPSDG GKDDDAFSES
     GEMEGFNSGL NSGGSTNSSP KVSPKLAPPK AGSKNLSNKK SLLQPKEKEE KNRDKNKVCT
     EKPVKEEKDQ VTEMAPKKTS KIASLIPKGS KTTAAKKESL IPSSSGIPKP GSKVPTVKQT
     ISPGSTASKE SEKFRTTKGS PSQSLSKPIT MEKASASSCP APLEGREAGQ ASPSGSCTMT
     VAQSSGQSTG NGAVQLPQQQ QHSHPNTATV APFIYRAHSE NEGTALPSAD SCTSPTKMDL
     SYSKTAKQCL EEISGEDPET RRMRTVKNIA DLRQNLEETM SSLRGTQISH STLETTFDST
     VTTEVNGRTI PNLTSRPTPM TWRLGQACPR LQAGDAPSLG AGYPRSGTSR FIHTDPSRFM
     YTTPLRRAAV SRLGNMSQID MSEKASSDLD MSSEVDVGGY MSDGDILGKS LRTDDINSGY
     MTDGGLNLYT RSLNRIPDTA TSRDIIQRGV HDVTVDADSW DDSSSVSSGL SDTLDNISTD
     DLNTTSSVSS YSNITVPSRK NTQLRTDSEK RSTTDETWDS PEELKKPEED FDSHGDAGGK
     WKTVSSGLPE DPEKAGQKAS LSVSQTGSWR RGMSAQGGAP SRQKAGTSAL KTPGKTDDAK
     ASEKGKAPLK GSSLQRSPSD AGKSSGDEGK KPPSGIGRST ATSSFGFKKP SGVGSSAMIT
     SSGATITSGS ATLGKIPKSA AIGGKSNAGR KTSLDGSQNQ DDVVLHVSSK TTLQYRSLPR
     PSKSSTSGIP GRGGHRSSTS SIDSNVSSKS AGATTSKLRE PTKIGSGRSS PVTVNQTDKE
     KEKVAVSDSE SVSLSGSPKS SPTSASACGA QGLRQPGSKY PDIASPTFRR LFGAKAGGKS
     ASAPNTEGVK SSSVMPSPST TLARQGSLES PSSGTGSMGS AGGLSGSSSP LFNKPSDLTT
     DVISLSHSLA SSPASVHSFT SGGLVWAANM SSSSAGSKDT PSYQSMTSLH TSSESIDLPL
     SHHGSLSGLT TGTHEVQSLL MRTGSVRSTL SESMQLDRNT LPKKGLRYTP SSRQANQEEG
     KEWLRSHSTG GLQDTGNQSP LVSPSAMSSS AAGKYHFSNL VSPTNLSQFN LPGPSMMRSN
     SIPAQDSSFD LYDDSQLCGS ATSLEERPRA ISHSGSFRDS MEEVHGSSLS LVSSTSSLYS
     TAEEKAHSEQ IHKLRRELVA SQEKVATLTS QLSANAHLVA AFEKSLGNMT GRLQSLTMTA
     EQKESELIEL RETIEMLKAQ NSAAQAAIQG ALNGPDHPPK DLRIRRQHSS ESVSSINSAT
     SHSSIGSGND ADSKKKKKKN WVNSRGSELR SSFKQAFGKK KSTKPPSSHS DIEELTDSSL
     PASPKLPHNA GDCGSASMKP SQSASASPLV WPPKKRQNGP VIYKHRSRIC ECTEAEAEII
     LQLKSELREK ELKLTDIRLE ALSSAHHLDQ IREAMNRMQN EIEILKAEND RLKAETGNTA
     KPTRPPSESS SSTSSSSSRQ SLGLSLNNLN ITEAVSSDIL LDDAGDATGH KDGRSVKIIV
     SISKGYGRAK DQKSQAYLIG SIGVSGKTKW DVLDGVIRRL FKEYVFRIDT STSLGLSSDC
     IASYCIGDLI RSHNLEVPEL LPCGYLVGDN NIITVNLKGV EENSLDSFVF DTLIPKPITQ
     RYFNLLMEHH RIILSGPSGT GKTYLANKLA EYVITKSGRK KTEDAIATFN VDHKSSKELQ
     QYLANLAEQC SADNNGVELP VVIILDNLHH VGSLSDIFNG FLNCKYNKCP YIIGTMNQGV
     SSSPNLELHH NFRWVLCANH TEPVKGFLGR YLRRKLIEIE IERNIRNNDL VKIIDWIPKT
     WHHLNSFLET HSSSDVTIGP RLFLPCPMDV EGSRVWFMDL WNYSLVPYIL EAVREGLQMY
     GKRTPWEDPS KWVLDTYPWS SATLPQESPA LLQLRPEDVG YESCTSTKEA TTSKHIPQTD
     TEGDPLMNML MKLQEAANYS STQSCDSEST SHHEDILDSS LESTL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024